Glaucoma: Clinical Trials

2,113 trials for Glaucoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1248 completed, 362 unknown, 176 recruiting, 124 terminated. 758 Not applicable, 278 Phase 4, 241 Phase 3, 225 Phase 2, 113 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable758Completed 368, Unknown 162, Recruiting 89, Terminated 54, Not yet recruiting 28, Withdrawn 24, Active not recruiting 23, Enrolling by invitation 7, Suspended 3
Phase 4278Completed 194, Unknown 32, Terminated 19, Recruiting 14, Withdrawn 8, Not yet recruiting 6, Active not recruiting 5
Phase 3241Completed 178, Unknown 23, Terminated 13, Recruiting 12, Withdrawn 8, Active not recruiting 2, Not yet recruiting 2, Suspended 2, Enrolling by invitation 1
Phase 2225Completed 169, Unknown 22, Recruiting 9, Active not recruiting 8, Terminated 8, Withdrawn 5, Not yet recruiting 2, Enrolling by invitation 1, Suspended 1
Phase 1113Completed 70, Unknown 17, Recruiting 7, Active not recruiting 6, Terminated 6, Withdrawn 3, Not yet recruiting 2, Enrolling by invitation 1, Suspended 1
Early Phase 113Completed 8, Unknown 3, Active not recruiting 1, Recruiting 1

Follow Glaucoma: new trials by email Literature Review of Glaucoma trials Research Report on Glaucoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
brimonidine tartrate ophthalmic solution 0.025%, sterile balanced saline solution - Glaucoma, Glaucoma, Open-Angle
Phase 4Not yet recruitingTulane University602027-11-012026-10-13
Know Your Pressures NYC
Virtual Automated Navigator Intervention with Health Education, Usual Care - Glaucoma, Hypertension
Not applicableNot yet recruitingColumbia University70852027-07-012026-08-25
Nicotinamide for Retinal Protection in Primary Open-Angle Glaucoma (NADIR Trial)
Nicotinamide, Standard Glaucoma Therapy - Glaucoma, Open-angle, Primary Open Angle Glaucoma (POAG)
Phase 2Not yet recruitingUniversity of Chicago962027-06-012026-10-13
Glaucoma Drop Aids Part 2
Nanodropper - Glaucoma, Intraocular Pressure
Not applicableNot yet recruitingBoston Medical Center802027-01-012026-10-30
VGFTe-(HD)-OD-2566: Adjunctive Aflibercept Ahmed Glaucoma Valve (AAA) Study
Aflibercept Injection, Ahmed Tube Surgery - Glaucoma
Phase 2Not yet recruitingUniversity of Miami1002026-12-012026-10-23
Impact of Meditation on Reducing Stress in Glaucoma Patients: An Electronic Feasibility Study
Meditation + Usual Care - Glaucoma
Not applicableNot yet recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1582026-11-012026-08-18
PAUL® Glaucoma Implant Safety and Effectiveness Study
PAUL® Glaucoma Implant - Refractory Glaucoma
Not applicableNot yet recruitingClinical Research Consultants, Inc.652026-11-012026-10-30
Baerveldt Versus Paul Study
Baerveldt Glaucoma Implant, Paul Glaucoma Implant - Glaucoma
Phase 4Not yet recruitingUniversity of Sydney1502026-10-122026-08-03
A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage
ASP2767, Sham ASP2767, Prophylactic Regimen A - Glaucoma
Phase 1 / Phase 2RecruitingAstellas Pharma Global Development, Inc.1562026-10-072026-10-22
Switching From Preserved Glaucoma Therapy to Preservative-Free ZOLYMBUS
preservative free ZOLYMBUS™ 0.01%. - Eye Drops Self-instillation, Glaucoma
Phase 4Not yet recruitingSouthern College of Optometry402026-10-052026-09-28
Iopidine to Decrease Intraocular Pressure Rise After Injections
Apraclonidine 1.0% ophthalmic solution - Macular Degeneration, Diabetic Retinopathy
Phase 4Not yet recruitingRetina Consultants of Delmarva1202026-10-012026-10-23
Evaluation the Safety and Effectiveness of the GORE GDI in Adult Subjects With Primary Open-angle Glaucoma in Whom Previous Medical and Surgical Treatment Have Failed.
GORE Glaucoma Drainage Implant - Glaucoma, Primary Open Angle
Not applicableNot yet recruitingGore Ophthalmic702026-10-012026-10-19
GlaukomAI: Clinical Validation of an AI System for Early Glaucoma Screening
GlaukomAI (Sens-vue GlaukomAI) - Glaucoma
Not applicableNot yet recruitingFondazione G.B. Bietti, IRCCS12002026-10-012026-09-04
Trabeculectomy Versus MicroShunt Implantation in Glaucoma Surgery (TIGER)
Preserflo MicroShunt, Trabeculectomy - Glaucoma
Not applicableNot yet recruitingOslo University Hospital1002026-10-012026-10-09
Combined Phacoemulsification-Goniotomy in Primary Open-Angle and Primary Angle-Closure Glaucoma
Combined Phacoemulsification and Goniotomy - Primary Open-Angle Glaucoma, Primary Angle-Closure Glaucoma
Not applicableNot yet recruitingAssiut University702026-10-012026-09-16
Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients
Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA], Timolol Maleate 0.25% Ophthalmic Solution - Open Angle Glaucoma (OAG), Glaucoma
Phase 4RecruitingBrett King132026-10-012026-10-28
Visual Function and Exercise in Glaucoma Patients
answer questionnaire - Glaucoma, Exercise
Not yet recruitingShanghai General Hospital, Shanghai Jiao Tong University School of Medicine1002026-09-302026-09-17
Ocular Surface Disease in Glaucoma Patients on Long-Term Therapy
Glaucoma, Ocular Surface Disease
Not yet recruitingAssiut University552026-09-262026-09-28
Comparative Study of the Tomey FT-1000, and Goldmann Applanation Tonometer (GAT)
Non Contact Tonometer and Applanation Tonometer - Glaucoma
RecruitingTomey Corporation302026-09-232026-10-06
Efficacy and Safety of a Releasable Intraluminal Suture Technique to Reduce Hypotony Following Glaucoma Surgery Using the Preserflo Device
Classical surgery, Intraluminal suture - Glaucoma
Not applicableRecruitingHôpital Privé de la Baie1922026-09-172026-10-02

Showing 20 of 2113. Sign in to see all of them.

Narrower conditions

Glaucoma, Open-Angle (917)  ·  Ocular Hypertension (614)  ·  Cataract (104)  ·  Glaucoma, Angle-Closure (87)  ·  Low Tension Glaucoma (65)  ·  Eye Diseases (53)  ·  Diabetic Retinopathy (47)  ·  Macular Degeneration (47)  ·  Exfoliation Syndrome (42)  ·  Glaucoma, Neovascular (39)  ·  Hydrophthalmos (37)  ·  Hypertension (30)  ·  Retinal Diseases (23)  ·  Patient Compliance (20)

Broader conditions

Eye Diseases (2060)  ·  Ocular Hypertension (1499)  ·  Lens Diseases (106)  ·  Cardiovascular Diseases (98)  ·  Vascular Diseases (97)  ·  Nervous System Diseases (83)  ·  Retinal Diseases (81)  ·  Optic Nerve Diseases (71)  ·  Pathological Conditions, Signs and Symptoms (67)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (63)  ·  Uveal Diseases (59)  ·  Endocrine System Diseases (55)  ·  Retinal Degeneration (55)  ·  Behavior (49)

Interventions

Latanoprost (164)  ·  Timolol (128)  ·  Travoprost (104)  ·  Ophthalmic Solutions (84)  ·  Bimatoprost (79)  ·  Trabeculectomy (75)  ·  Brimonidine Tartrate (59)  ·  brinzolamide (55)  ·  dorzolamide (40)  ·  dorzolamide-timolol combination (39)  ·  Phacoemulsification (37)  ·  Cataract Extraction (32)  ·  Mitomycin (30)  ·  Duotrav (24)  ·  tafluprost (22)

Sponsors

Alcon Research (135)  ·  Allergan (82)  ·  Glaukos Corporation (48)  ·  Wills Eye (48)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (27)  ·  Aerie Pharmaceuticals (25)  ·  Medical University of Vienna (24)  ·  Sensimed AG (22)  ·  Sun Yat-sen University (22)  ·  Universitaire Ziekenhuizen KU Leuven (20)  ·  University of Zurich (20)  ·  Zhongshan Ophthalmic Center, Sun Yat-sen University (18)  ·  Aristotle University Of Thessaloniki (17)  ·  Duke University (17)  ·  Stanford University (16)

Countries

United States (721)  ·  Canada (112)  ·  China (112)  ·  Germany (101)  ·  France (77)  ·  Egypt (75)  ·  Italy (74)  ·  United Kingdom (74)  ·  Spain (69)  ·  Switzerland (61)  ·  South Korea (54)  ·  Austria (53)  ·  Belgium (45)  ·  Israel (38)  ·  Singapore (36)

Top investigators

Ingeborg Stalmans, MD, PhD (9)  ·  Anastasios G Konstas, MD, PhD (7)  ·  George L Spaeth, MD (7)  ·  Robert Ritch, MD (7)  ·  Theresa Heah, MD (7)  ·  William C. Stewart, MD (7)  ·  Zubair Hussain, PhD (7)  ·  Gong Je Seong, MD, PhD (6)  ·  Jeffrey L Goldberg, MD, PhD (6)

Results publications

PMID 35943114, PMID 36912740, PMID 10937547, PMID 24974815, PMID 17122118, PMID 12049574, PMID 19427617, PMID 24210765, PMID 35643967, PMID 40408035, PMID 11772581, PMID 12365904, PMID 16249960, PMID 16488940, PMID 17159450, PMID 19277230, PMID 19476406, PMID 22427577, PMID 22607109, PMID 23557744, PMID 23746612, PMID 25336577, PMID 25358735, PMID 26199618, PMID 26604914, PMID 26674779, PMID 26891880, PMID 27117781, PMID 27769587, PMID 27857759, PMID 27904503, PMID 28551166, PMID 29194198, PMID 29267575, PMID 29477688, PMID 29613978, PMID 31294768, PMID 31727428, PMID 32166538, PMID 32277009, PMID 34003939, PMID 34433548, PMID 34707360, PMID 35076329, PMID 36122660, PMID 36378864, PMID 37010901, PMID 37793935, PMID 38985408, PMID 39240530

NIH funding

2014 (5), 2018 (5), 2008 (4), 2015 (4), 2019 (4), 2009 (3), 2023 (3), 2016 (2), P30AG022838 (2), R01EY013178 (2), R01EY022124 (2), R01EY023285 (2), U01DP006820 (2), UL1TR001082 (2), 2017 (1)